Bailard, Inc. Lian Bio Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$1.87 - $3.0 $52,343 - $83,973	-27,991 Reduced 58.81%	19,606 $39,000
Q2 2022 Jul 27, 2022	BUY	$2.15 - $6.01 $22,998 - $64,288	10,697 Added 28.99%	47,597 $103,000
Q1 2022 Apr 25, 2022	BUY	$2.8 - $6.21 $103,320 - $229,149	36,900 New	36,900 $137,000

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $31.4M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.